InvestorsHub Logo
Followers 62
Posts 7504
Boards Moderated 1
Alias Born 01/02/2003

Re: BioChica post# 32680

Friday, 08/22/2014 9:31:09 AM

Friday, August 22, 2014 9:31:09 AM

Post# of 424157
As good these numbers look, they should even be better. Kowa reps are dependent of Kowa for their salaries and ultimately their jobs. These, in turn, depend primarily on pleasing their Kowa supervisors by selling Livalo. Selling Vascepa would be nice, but it is for them, of secondary importance to selling Livalo. I am in favor of providing further financial incentives for reps to promote Vascepa and I hope this is being done. If not, I hope the reps performance ratings are being evaluated on the combined sales of Vascepa and Livalo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News